Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amphastar Pharmaceuticals Inc (AMPH) vs Plby Group Inc (PLBY) Price & Performance

Amphastar Pharmaceuticals IncTrade
Plby Group IncTrade

Price performance (Past 24H)

Key statistics

Amphastar Pharmaceuticals Inc vs Plby Group Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Plby Group Inc trades at $1.33 (market cap $162.94M). The key difference: Amphastar Pharmaceuticals Inc is far larger — about 5.3× Plby Group Inc's market cap, and Amphastar Pharmaceuticals Inc is trading nearer its 52-week high, Plby Group Inc nearer its low. Which is the better fit depends on your goals.

AMPHPLBY
Market Cap
$868.62M$162.94M
Sector
HealthConsumer Cyclical
52-Week High
$30.81$2.71
52-Week Low
$16.87$1.11
Enterprise Value
$1.27B$308.52M

Returns comparison

Trailing returns across standard periods

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH

About Plby Group Inc

PLBY Group Inc is a pleasure and leisure company. The company's segment includes Licensing, Direct-to-Consumer, and Digital Subscriptions and Content. It generates maximum revenue from the Direct-to-Consumer segment. Direct-to-Consumer operations include consumer products sold through third-party retailers or online direct-to-customer. Geographically, it derives a majority of revenue from the United States.

Read more on PLBY